Laboratoire de Chimie de Coordination UPR 8241

Accueil > EQUIPES > Equipe V



Huang, D., Li, Y., Liu, Y., & Meunier, B. (2019). Synthesis and chelation selectivity evaluation of 8-aminoquinoline derivatives as copper chelator. Chin. J. Org. Chem., 39(2), 500–506.
Paloque, L., Perez-Berezo, T., Abot, A., Dalloux-Chioccioli, J., Bourgeade-Delmas, S., Le Faouder, P., Pujo, J., Teste, M. - A., François, J. - M., Schebb, N. H., Mainka, M., Rolland, C., Blanpied, C., Dietrich, G., Bertrand-Michel, J., Deraison, C., Valentin, A., & Cenac, N. (2019). Polyunsaturated fatty acid metabolites: Biosynthesis in Leishmania and role in parasite/host interaction. J. Lipid Res., 60(3), 636–647.


Gendrot, M., Foguim Tsombeng, F., Robert, M. G., Amalvict, R., Mosnier, J., Benoit, N., Madamet, M., Pradines, B., & the French National Reference Centre for Imported Malaria Study Group. (2018). The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates. Malaria Journal, 17(1), 108.
Gumpelmayer, M., Nguyen, M., Molnar, G., Bousseksou, A., Meunier, B., & Robert, A. (2018). Magnetite Fe3O4 has no intrinsic peroxidase activity, and is probably not involved in Alzheimer's oxidative stress. Angew. Chem., Int. Ed., 57, 14758 –14763.
Laborde, J., Deraeve, C., de Mesquita Vieira, F. G., Sournia-Saquet, A., Rechignat, L., Drumond Villela, A., Lopes Abbadi, B., Souza Macchi, F., Pissinati, K., Bizarro, C. V., Machado, P., Augusto Basso, L., Pratviel, G., Gonzaga de França Lopes, L., Silva Sousa, E. H., & Bernardes-Genisson, V. (2018). Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy. J. Inorg. Biochem., 179, 71–81.
Lee, V. Y., Kawai, M., Gapurenko, O. A., Minkin, V. I., Gornitzka, H., & Sekiguchi, A. (2018). Arsagermene, a compound with an –As=Ge–(R1;R2) double bond. Chem. Commun., 54(78), 10947–10949.
Lee, V. Y., Sugasawa, H., Gapurenko, O. A., Minyaev, R. M., Minkin, V. I., Gornitzka, H., & Sekiguchi, A. (2018). From borapyramidane to borole dianion. J. Am. Chem. Soc., 140(19), 6053–6056.
Meunier, B. (2018). Alzheimer : quand allons-nous avoir des médicaments efficaces ? Actualité Chimique, 433, 7.
Niare, K., Paloque, L., Menard, S., Tor, P., Ramadani, A. P., Augereau, J. - M., Dara, A., Berry, A., Benoit-Vical, F., & Doumbo, O. K. (2018). Multiple phenotypic and genotypic artemisinin sensitivity evaluation of Malian Plasmodium falciparum isolates. Am. J. Trop. Med. Hyg., 98(4), 1123–1131.
Ouji, M., Augereau, J. - M., Paloque, L., & Benoit-Vical, F. (2018). Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination. Parasite, 25, 24.
Paloque, L., Witkowski, B., Lelievre, J., Ouji, M., Ben Haddou, T., Ariey, F., Robert, A., Augereau, J. - M., Menard, D., Meunier, B., & Benoit-Vical, F. (2018). Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism. J. Antimicrob. Chemother., 73(2), 395–403.
Paludetto, M. - N., Bijani, C., Puisset, F., Bernardes-Genisson, V., Arellano, C., & Robert, A. (2018). Metalloporphyrin-catalyzed oxidation of sunitinib and pazopanib, two anticancer tyrosine kinase inhibitors: Evidence for new potentially toxic metabolites. J. Med. Chem., 61(17), 7849–7860.
Ramadani, A. P., Paloque, L., Belda, H., Tamhid, H. A., Masriani, J., Augereau, J. - M., Valentin, A., Wijayanti, M. A., Mustofa, & Benoit-Vical, F. (2018). Antiprotozoal properties of Indonesian medicinal plant extracts. J. Herb. Med., 11, 46–52.
Robert, M. G., Foguim Tsombeng, F., Gendrot, M., Mosnier, J., Amalvict, R., Benoit, N., Torrentino-Madamet, M., & Pradines, B. (2018). Absence of a high level of duplication of the Plasmepsin II gene in Africa. Antimicrob. Agents Chemother., 62(11), e00374–18.
Zhang, C., Bourgeade Delmas, S., Fernández Alvarez, A., Valentin, A., Hemmert, C., & Gornitzka, H. (2018). Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes. Eur. J. Med. Chem., 143, 1635–1643.
Zhang, C., Hemmert, C., Gornitzka, H., Cuvillier, O., Zhang, M., & Sun, R. W. - Y. (2018). Cationic and neutral N-heterocyclic carbene gold(I) complexes: Cytotoxicity, NCI-60 screening, cellular uptake, inhibition of mammalian thioredoxin reductase, and reactive oxygen species formation. ChemMedChem, 13(12), 1218–1229.
Zhang, C., Maddelein, M. - L., Sun, R. W. - Y., Gornitzka, H., Cuvillier, O., & Hemmert, C. (2018). Pharmacomodulation on Gold-NHC complexes for anticancer applications – is lipophilicity the key point? Eur. J. Med. Chem., 157, 320–332.
Zhang, W., Huang, D., Huang, M., Huang, J., Wang, D., Liu, X., Nguyen, M., Vendier, L., Mazères, S., Robert, A., Liu, Y., & Meunier, B. (2018). Preparation of tetradentate copper chelators as potential anti‐Alzheimer agents. ChemMedChem, 13(7), 684–704.
Zhang, W., Huang, M., Bijani, C., Liu, Y., Robert, A., & Meunier, B. (2018). Synthesis and characterization of copper-specific tetradendate ligands as potential treatment for Alzheimer's disease. C. R. Chimie, 21(5), 475–483.
Zhang, W., Liu, Y., Hureau, C., Robert, A., & Meunier, B. (2018). N4‐Tetradentate chelators efficiently regulate copper homeostasis and prevent ROS production induced by copper‐amyloid‐β1–16. Chem. – Eur. J., 24(31), 7825–7829.